Cargando…
The impact of microbial keratitis on quality of life in Uganda
BACKGROUND: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. METHODS: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936408/ https://www.ncbi.nlm.nih.gov/pubmed/31909191 http://dx.doi.org/10.1136/bmjophth-2019-000351 |
_version_ | 1783483726909407232 |
---|---|
author | Arunga, Simon Wiafe, Geoffrey Habtamu, Esmael Onyango, John Gichuhi, Stephen Leck, Astrid Macleod, David Hu, Victor Burton, Matthew |
author_facet | Arunga, Simon Wiafe, Geoffrey Habtamu, Esmael Onyango, John Gichuhi, Stephen Leck, Astrid Macleod, David Hu, Victor Burton, Matthew |
author_sort | Arunga, Simon |
collection | PubMed |
description | BACKGROUND: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. METHODS: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with MK at two eye units in Southern Uganda between December 2016 and March 2018 and unaffected individuals, individually matched for sex, age and location. QoL was measured using WHO Health-Related and Vision-Related QoL tools (at presentation and 3 months after start of treatment in cases). Mean QoL scores for both groups were compared. Factors associated with QoL among the cases were analysed in a linear regression model. RESULTS: 215 case-controls pairs were enrolled. The presentation QoL scores for the cases ranged from 20 to 65 points. The lowest QoL was visual symptom domain; mean 20.7 (95% CI 18.8 to 22.7) and the highest was psychosocial domain; mean 65.6 (95% CI 62.5 to 68.8). At 3 months, QoL scores for the patients ranged from 80 to 90 points while scores for the controls ranged from 90 to 100. The mean QoL scores of the cases were lower than controls across all domains. Determinants of QoL among the cases at 3 months included visual acuity at 3 months and history of eye loss. CONCLUSION: MK severely reduces QoL in the acute phase. With treatment and healing, QoL subsequently improves. Despite this improvement, QoL of someone affected by MK (even with normal vision) remains lower than unaffected controls. |
format | Online Article Text |
id | pubmed-6936408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-69364082020-01-06 The impact of microbial keratitis on quality of life in Uganda Arunga, Simon Wiafe, Geoffrey Habtamu, Esmael Onyango, John Gichuhi, Stephen Leck, Astrid Macleod, David Hu, Victor Burton, Matthew BMJ Open Ophthalmol Original Research BACKGROUND: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. METHODS: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with MK at two eye units in Southern Uganda between December 2016 and March 2018 and unaffected individuals, individually matched for sex, age and location. QoL was measured using WHO Health-Related and Vision-Related QoL tools (at presentation and 3 months after start of treatment in cases). Mean QoL scores for both groups were compared. Factors associated with QoL among the cases were analysed in a linear regression model. RESULTS: 215 case-controls pairs were enrolled. The presentation QoL scores for the cases ranged from 20 to 65 points. The lowest QoL was visual symptom domain; mean 20.7 (95% CI 18.8 to 22.7) and the highest was psychosocial domain; mean 65.6 (95% CI 62.5 to 68.8). At 3 months, QoL scores for the patients ranged from 80 to 90 points while scores for the controls ranged from 90 to 100. The mean QoL scores of the cases were lower than controls across all domains. Determinants of QoL among the cases at 3 months included visual acuity at 3 months and history of eye loss. CONCLUSION: MK severely reduces QoL in the acute phase. With treatment and healing, QoL subsequently improves. Despite this improvement, QoL of someone affected by MK (even with normal vision) remains lower than unaffected controls. BMJ Publishing Group 2019-12-23 /pmc/articles/PMC6936408/ /pubmed/31909191 http://dx.doi.org/10.1136/bmjophth-2019-000351 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Arunga, Simon Wiafe, Geoffrey Habtamu, Esmael Onyango, John Gichuhi, Stephen Leck, Astrid Macleod, David Hu, Victor Burton, Matthew The impact of microbial keratitis on quality of life in Uganda |
title | The impact of microbial keratitis on quality of life in Uganda |
title_full | The impact of microbial keratitis on quality of life in Uganda |
title_fullStr | The impact of microbial keratitis on quality of life in Uganda |
title_full_unstemmed | The impact of microbial keratitis on quality of life in Uganda |
title_short | The impact of microbial keratitis on quality of life in Uganda |
title_sort | impact of microbial keratitis on quality of life in uganda |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936408/ https://www.ncbi.nlm.nih.gov/pubmed/31909191 http://dx.doi.org/10.1136/bmjophth-2019-000351 |
work_keys_str_mv | AT arungasimon theimpactofmicrobialkeratitisonqualityoflifeinuganda AT wiafegeoffrey theimpactofmicrobialkeratitisonqualityoflifeinuganda AT habtamuesmael theimpactofmicrobialkeratitisonqualityoflifeinuganda AT onyangojohn theimpactofmicrobialkeratitisonqualityoflifeinuganda AT gichuhistephen theimpactofmicrobialkeratitisonqualityoflifeinuganda AT leckastrid theimpactofmicrobialkeratitisonqualityoflifeinuganda AT macleoddavid theimpactofmicrobialkeratitisonqualityoflifeinuganda AT huvictor theimpactofmicrobialkeratitisonqualityoflifeinuganda AT burtonmatthew theimpactofmicrobialkeratitisonqualityoflifeinuganda AT arungasimon impactofmicrobialkeratitisonqualityoflifeinuganda AT wiafegeoffrey impactofmicrobialkeratitisonqualityoflifeinuganda AT habtamuesmael impactofmicrobialkeratitisonqualityoflifeinuganda AT onyangojohn impactofmicrobialkeratitisonqualityoflifeinuganda AT gichuhistephen impactofmicrobialkeratitisonqualityoflifeinuganda AT leckastrid impactofmicrobialkeratitisonqualityoflifeinuganda AT macleoddavid impactofmicrobialkeratitisonqualityoflifeinuganda AT huvictor impactofmicrobialkeratitisonqualityoflifeinuganda AT burtonmatthew impactofmicrobialkeratitisonqualityoflifeinuganda |